Pooja A Chawla is working as a Professor, at the University Institute of Pharmaceutical Sciences, Baba Farid University of Health Sciences, Faridkot, Punjab, India. She has more than 23 years of experience in the research, discovery, and development of biologically active pharmaceuticals. She holds a PhD degree in Pharmaceutical Sciences with a specialization in Chemistry and has published 9 books, 50 book chapters, and more than 200 papers in national/international journals and is serving as a reviewer for international journals of repute. She is also privileged to serve as guest editor of two reputed journals CNS & Neurological Disorders - Drug Targets IF 3.0 and Current Organic Chemistry IF 2.1 of Bentham Sciences. She has been appointed as Academic editor of PLOS ONE journal IF 2.6 and she has been serving as Assistant editor for Health Sciences Review Journal by Elsevier publishers. She has guided more than 60 postgraduate projects and her research team consists of 3 Masters and 4 Doctoral research scholars. She has seven published patents and five design patents to her credit. Her area of research interest focuses on the design and synthesis of various heterocyclic moieties including 4-Thiazolidinones, 2,4-Thiazolidiedione, Coumarin, Pyrazolines, Schiff's base derivatives to name a few for the discovery of medicinally important agents as anticonvulsants, antidepressants, anticancer, anti-Alzheimer's agents. She is well-versed with method development and validation and guiding research scholars in this field.